Incannex says cannabidiol-hydroxychloroquine cocktail shows promise in new animal study

Special Report: Medical cannabis company Incannex Healthcare (ASX:IHL) says a mice study has further vindicated its cannabidiol/hydroxychloroquine combination pharmaceutical drug,  … Read More

The post Incannex says cannabidiol-hydroxychloroquine cocktail shows promise in new animal study appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *